Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1

Yili Yin, Bénédicte Manoury and Robin Fåhraeus
Science
New Series, Vol. 301, No. 5638 (Sep. 5, 2003), pp. 1371-1374
Stable URL: http://www.jstor.org/stable/3835027
Page Count: 4
  • More info
  • Cite this Item
Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1
Preview not available

Abstract

The glycine-alanine repeat domain (GAr) of Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) prevents major histocompatibility complex (MHC) class I-restricted presentation of EBNA1 epitopes to cytotoxic T cells. This effect has previously been attributed to the ability of GAr to inhibit its own proteasomal degradation. Here we show, both in vitro and in vivo, that GAr also inhibits messenger RNA translation of EBNA1 in cis and that this effect can be distinguished from its effect on proteasomal degradation. Hence, inhibition of messenger RNA translation, but not protein degradation, is essential to prevent antigen presentation on MHC class I molecules. Thus, by minimizing translation of the EBNA1 transcript, cells expressing EBNA1 avoid cytotoxic T cell recognition. At the same time, blocking degradation maintains the EBNA1 expression level.

Page Thumbnails

  • Thumbnail: Page 
1371
    1371
  • Thumbnail: Page 
1372
    1372
  • Thumbnail: Page 
1373
    1373
  • Thumbnail: Page 
1374
    1374